Group effects EMA [Two-Stage / GS Designs]

posted by VStus – Poland, 2016-10-07 00:06 (2750 d 11:41 ago) – Posting: # 16701
Views: 35,468

Hi Helmut,

I have performed exercise on this dataset in R and have to support Mittyri: addition of more effects beyond group increases MSE and, therefore, CI:

anova(lm(log(response) ~ sequence + subject:sequence + period + treatment, data=data, na.action=na.exclude))["Residuals","Mean Sq"]
[1] 0.00075363
anova(lm(log(response) ~ sequence + subject:sequence + period + treatment + group, data=data, na.action=na.exclude))["Residuals","Mean Sq"]
[1] 0.00075363
anova(lm(log(response) ~ sequence + subject:sequence + period + treatment + group + period:group, data=data, na.action=na.exclude))["Residuals","Mean Sq"]
[1] 0.00078534


Due to my limited R knowledge, I cannot figure out how to add other effects recommended by FDA e.g. subject(sequence x group), but I'm afraid that at least in R, the more related effects - the wider confidence intervals...

Regards, VStus

Complete thread:

UA Flag
Activity
 Admin contact
22,986 posts in 4,823 threads, 1,661 registered users;
78 visitors (0 registered, 78 guests [including 4 identified bots]).
Forum time: 11:48 CEST (Europe/Vienna)

Art is “I”; science is “we”.    Claude Bernard

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5